ytterbium yb-169 Report issue

Small molecule Experimental

Active Ingredient History

Yb-169 is a radioisotope of rare-earth element ytterbium. Yb-169 emits gamma-photons with an average energy of 93 keV and decays with a half‐life of 32 days. Yb-169 has an application to brachytherapy. Implants for direction modulated brachytherapy are developed for the treatment of locally advanced cervical cancer. Yb-169 was suggested for the use in intravascular brachytherapy for the treatment of arterial restenosis. An injected complex of Yb-169 with DPTA was used for the treatment of internal contamination with americium, curium, or plutonium and other conditions.   NCATS

Chemistry

  • SMILES: [169Yb]
  • InChIKey: NAWDYIZEMPQZHO-AHCXROLUSA-N
  • Mol. Mass: 168.93518712
  • ALogP: Missing data
  • ChEMBL Molecules: Missing data
More Chemistry

Pharmacology

Indications (1)

Approved Indications (1)


 

Food Contamination, Radioactive (approved 1976)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue